Physician decision-making on use of treatments for relapsed/refractory multiple myeloma (RRMM) in later lines: What drives preferences?

239Background: Physicians consider many factors when selecting third line or greater (3L+) treatments for RRMM, such as patient age and treatment- and disease-specific factors. A greater understand...